Long ‐term Follow‐up of Chemoimmunotherapy with Rituximab, Oxaliplatin, Cytosine Arabinoside, Dexamethasone (ROAD) in Patients With Relapsed CD20+ B–Cell Non‐Hodgkin Lymphoma: Results of a study of the Mayo Clinic Cancer Research Consortium (MCCRC) MC0485 now known as Academic and Community Cance r Research United (ACCRU)

This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - June 15, 2017 Category: Hematology Authors: Thomas E. Witzig, Patrick B. Johnston, Betsy R. LaPlant, Paul J. Kurtin, Levi D. Pederson, Dennis F. Moore, Nassim H. Nabbout, Daniel A. Nikcevich, Kendrith M. Rowland, Axel Grothey Tags: Research Article Source Type: research